Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

IBB vs. FBDIX: which is better?

Bottom line

IBB vs FBDIX: the short answer

IBB (iShares Biotechnology ETF) and FBDIX (Franklin Biotechnology Discovery Fund) are quite different portfolios: only about 34% of their top holdings (by weight) are shared.

But IBB is far broader, holding 254 positions to 126 for FBDIX, so beyond the top names it adds exposure FBDIX doesn't have.

IBB is cheaper at 0.44% vs 1.01% — a difference of $57 a year per $10,000 invested.

Over five years, FBDIX returned +5.0% a year vs +2.5% for IBB.

FBDIX has a front-end sales load of up to 5.5%; the other does not.

Updated Nov 19, 2026

IBB vs FBDIX side by side

IBBFBDIX
TypeETFMutual fund
Fund familyiSharesFranklin Templeton
CategoryTechnology SectorTechnology Sector
Expense ratio0.44%1.01%
Annual cost per $10k$44$101
10-yr cost on $10k (prospectus)$555$1,728
Max front loadNone5.5%
12b-1 fee0%0.25%
1-yr return+28.0%+43.9%
5-yr return (annualized)+2.5%+5.0%
10-yr return (annualized)+4.4%+6.4%
Best quarter+26.8%+29.5%
Worst quarter−22.9%−24.5%
Net assets (fund)$5.9B$1.2B
Number of holdings254126
Portfolio turnover27%38%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearIBBFBDIXDifference
2025+28.0%+52.3%−24.3%
2024−2.4%+4.0%−6.4%
2023+3.6%+18.4%−14.8%
2022−13.6%−12.7%−0.9%
2021+1.0%−17.7%+18.7%
2020+25.9%+29.9%−4.0%
2019+24.8%+34.8%−10.1%
2018−9.1%−15.7%+6.6%
2017+21.2%+18.8%+2.4%
2016−21.5%−17.2%−4.4%

Source: Fund prospectus bar charts

Holdings overlap

7 of IBB's top 25 holdings also appear in FBDIX's top 25.

Shared top holdings
HoldingIBBFBDIX
Vertex Pharmaceuticals, Inc.7.66%3.54%
Gilead Sciences, Inc.7.52%3.86%
Amgen, Inc.7.50%4.39%
Regeneron Pharmaceuticals, Inc.5.70%3.77%
Argenx SE3.15%3.62%
Insmed, Inc.2.95%1.99%
Neurocrine Biosciences, Inc.1.34%1.82%

Source: SEC Form N-PORT

IBB top 10

  1. BlackRock Funds III — 13.18%
  2. Vertex Pharmaceuticals, Inc. — 7.66%
  3. Gilead Sciences, Inc. — 7.52%
  4. Amgen, Inc. — 7.50%
  5. Regeneron Pharmaceuticals, Inc. — 5.70%
  6. Alnylam Pharmaceuticals, Inc. — 5.68%
  7. IQVIA Holdings, Inc. — 3.18%
  8. Argenx SE — 3.15%
  9. Insmed, Inc. — 2.95%
  10. Mettler-Toledo International, Inc. — 2.49%

FBDIX top 10

  1. Jazz Pharmaceuticals plc — 5.66%
  2. Amgen, Inc. — 4.39%
  3. Gilead Sciences, Inc. — 3.86%
  4. Regeneron Pharmaceuticals, Inc. — 3.77%
  5. Argenx SE — 3.62%
  6. Vertex Pharmaceuticals, Inc. — 3.54%
  7. Franklin Institutional U.S. Government Money Market Fund — 3.18%
  8. Revolution Medicines, Inc. — 3.01%
  9. Guardant Health, Inc. — 2.76%
  10. Ascendis Pharma A/S — 2.56%

FAQ

What is the difference between IBB and FBDIX?
IBB (iShares Biotechnology ETF) and FBDIX (Franklin Biotechnology Discovery Fund) are quite different portfolios: only about 34% of their top holdings (by weight) are shared. But IBB is far broader, holding 254 positions to 126 for FBDIX, so beyond the top names it adds exposure FBDIX doesn't have.
Which is cheaper, IBB or FBDIX?
IBB has the lower expense ratio (0.44%).
Should I own both IBB and FBDIX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.